¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fluid mosaic model"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • psychodynamic experiential model
    Á¤½Å¿ªµ¿°æÇè¸ðÇü
  • reserve model
    ¿¹ºñ¸ðÇü
  • role model
    ¿ªÇÒÇ¥º»Çü, ¿ªÇÒ¸ðµ¨
  • social service model
    »çȸ¼­ºñ½º¸ðµ¨
  • statistical model
    Åë°è¸ðÇü
  • symmetry model
    ´ëĪÇü, ´ëμ³
  • sequential model
    ¼øÂ÷¸ðµ¨
  • single major gene locus model
    ´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
  • viscoelastic model
    Á¡µµÅº·Â¸ðÇü
  • working model
    ÀÛ¾÷¸ðÇü
  • wax model
    ¹Ð¶ø¸ðÇü
  • aqueous fluid
    ¹æ¼ö
  • ascitic fluid
    º¹¼ö
  • air fluid level
    °ø±â¾×üÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • plaster model
    ¼®°í¸ðÇü
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • psychodynamic experiential model
    Á¤½Å¿ªµ¿°æÇè¸ðÇü
  • reserve model
    ¿¹ºñ¸ðÇü
  • role model
    ¿ªÇÒÇ¥º»Çü
  • sequential model
    ¼øÂ÷¸ðµ¨
  • single major gene locus model
    ´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
  • social service model
    m. »çȸ¼­ºñ½º¸ðµ¨
  • statistical model
    Åë°è¸ðÇü
  • symmetry model
    ´ëĪÇü, ´ëμ³
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
  • viscoelastic model
    Á¡µµÅº·Â¸ðÇü
  • wax model
    ¹Ð¶ø¸ðÇü
  • working model
    ÀÛ¾÷¸ðÇü
  • air fluid level
    °ø±â¾×üÃþ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • amniotic fluid analysis
    ¾ç¼öºÐ¼®
  • amniotic fluid embolism
    ¾ç¼ö»öÀü(Áõ)(¡­ßáîûñø).
  • amniotic fluid surfactant
    ¾ç¼öÇ¥¸éȰ¼ºÁ¦
  • amniotic fluid<³ª> liquor aminil
    ¾ç¼ö(åÏâ©).
  • aqueous fluid
    ¹æ¼ö
  • free pleural fluid
    ÀÚÀ¯ ´Á¸· »ïÃâ¾×
  • gastric replacement fluid
    À§º¸¾×(êÖÜÍäû).
  • gelsemium fluid extract
    Á©¼¼¹ÅÀ¯µ¿(¡­êüÔÑ)ÃßÃâ¹°.
  • pleural effusion =p. fluid
    È丷À¯Ãâ.
  • pleural effusion =p. fluid
    È丷À¯Ãâ(ýØØ¯×µõó)
  • pleural effusion =p. fluid
    È丷À¯Ãâ.
  • pleural fluid
    Èä¼ö(ýØâ©).
  • pleural fluid
    Èä¼ö(ýØâ©)
  • pleural fluid
    Èä¼ö(ýØâ©)
  • prostatic fluid
    Àü¸³¼±¾×(îñí¡àÍäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • absolute risk model
    Àý´ëÀ§Çè¸ðµ¨
  • atomic model
    ¿øÀÚ¸ðÇü(¡­Ù¼úþ).
  • biopsychological model
    »ýü½É¸®ÇÐÀû ¸ðµ¨
  • bulk phase model
    µ¢¾î¸® À§»ó ¸ðÇü
  • compartmentalization model
    ±¸È¹È­ ¸ðÇü
  • core conductor model
    ÇÙÀüµµÃ¼¸ðÇü(ú·ï³Óôô÷Ù¼úþ).
  • developmental model
    ¹ß´Þ(Û¡Ó¹)¸ðÇü
  • double helix, DNA model
  • ear model(ITE), in the
    ±Í¼ÓÇü(º¸Ã»±â)
  • general linear model
    ÀϹÝÀû ¼±Çü ¸ðµ¨, ÀÏ¹Ý ¼±»ó ¸ðµ¨
  • gnathostatic model
    ¾ÇŸðÇü(¡­Ù¼úþ).
  • health belief model
    °Ç°­¹ÏÀ½ ¸ðÇü.
  • homeostatic model
    Ç×»ó¼º ¸ðÇü(Ù¼úþ)<Ç¥ÁØÇü>
  • in-the-ear model
    ±Í¼ÓÇü(º¸Ã»±â)
  • linear quadratic model
    ¼±Çü¹æÇü¸ðµ¨, ¼±ÇüÀÌÂ÷ÇÔ¼ö¸ðµ¨, LQ¸ðµ¨
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Holliday model
    ÇÒ·¯µ¥ÀÌ ¸ðµ¨
  • Huxley-Hanson model
    Çä½½¸®-Çî½¼ ¸ðµ¨
  • Huxley-Simmons model
    Çä½½¸®-½Ã¸ó½º ¸ðµ¨
  • insertion model
    »ðÀÔ(ߺìý)¸ðµ¨
  • Ising model
    ¾ÆÀÌ½Ì ¸ðµ¨
  • KNF model
    KNF ¸ðµ¨
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
  • leaky patch model
    ´©Ãâ(שõó) ÆäÄ¡¸ðµ¨
  • lethal mutation model
    Ä¡»çº¯ÀÌ(öÈÞÝܨì¶)¸ðµ¨
  • looped rolling circle model
    ·çÇÁÇü ȸÀü¿ø(üÞï®ê­)¸ðµ¨
  • master-slave model
    ÁÖÁ¾(ñ«ðô) ¸ðµ¨
  • mobile receptor model
    À̵¿¼ö¿ëü(ì¹ÔÑáôé»ô÷) ¸ðµ¨
  • model
    ¸ðµ¨
  • model system
    ¸ðµ¨½Ã½ºÅÛ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TMV tobacco mosaic virus
TYMV turnip yellow mosaic virus
AF abnormal frequency; acid-fast; adult female; afebrile; aflatoxin; albumin-free; albumose-free; aldeh...
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
ICF immunodeficiency-centromeric instability-facial anomalies [syndrome]; indirect centrifugal flotation...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
POHEM POpulation HEalth Model
TTM The Transtheoretical Model
UKM Urea kinetic model
MAIDS model of AIDS
ACMV African cassava mosaic virus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amniotic fluid embolism
    ¾ç¼ö »öÀüÁõ
    ºÐ¸¸ ½Ã¿Í ºÐ¸¸ Á÷ÈÄ¿¡ ¹ß»ýÇÏ´Â Áö±ØÈ÷ ÁßÇÑ ÇÕº´ÁõÀ¸·Î½á ÃâÇ÷, µ¶Ç÷Áõ, Æó»öÀüÁõ°ú °°Àº Ä¡¸íÀûÀÎ ÇÕº´Áõ°ú ÇÔ²² »ê¸ð »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎÀÌ µÇ°í ÀÖ´Ù. 5¸¸¸í Áß 1¸í²Ã·Î ¹ß»ýÇϸç 89%ÀÇ »ç¸Á·üÀ» º¸ÀδÙ.
  • bleaching fluid
    Ç¥¹é ¾×
  • blister fluid
    ¼öÆ÷ ¾×
  • blood cerebrospinal fluid barrier
    Ç÷³ú ô¼ö¾× À庮, Ç÷¾× ³úô¼ö¾× °ü¹®
  • body fluid compartment
    ü¾× ºÐȹ, ü¾× ±¸ºÐ
  • cerebrospinal fluid
    ³ú ô¼ö¾×
    ³ú, ô¼ö¸¦ ¼øÈ¯ÇÏ´Â ¾×ü.
  • cerebrospinal fluid leakage
    ³ú ô¼ö¾× À¯Ãâ
    »ç°ñÀÇ ¹Ì·Î ÆÇÀ» ÅëÇØ ¹èÃâµÇ¸ç 24½Ã°£ ³»Áö 72½Ã°£ À̳»¿¡ ¸ØÃß°Ô µÈ´Ù. Ưº°ÇÑ Ä¡·á¸¦ ÇÏÁö ¾Ê°í Ç×»ýÁ¦¸¦ Åõ¿©ÇÏ¸ç ±â´Ù¸°´Ù.
  • cerebrospinal fluid pressure
    ³ú ô¼ö¾× ¾Ð·Â
  • cooling fluid
    ³Ã°¢ ¾×
  • crevicular fluid
    ¿­±¸ ¾×
  • excessive fluid retention
    °úÀ× ¾×ü Àú·ù
  • extracellular fluid
    ¼¼Æ÷¿Ü ¾×
  • extravascular fluid
    Ç÷°ü¿Ü ¾×
  • fluid
    ¾×ü, À¯Ã¼, ¼öºÐ, ¿ë¾×, ü¾×
    ¾×ü ¶Ç´Â ±âü. ºÐ¸®µÇÁö ¾Ê°í ÀÚÀ¯·Ó°Ô »ó´ëÀû À§Ä¡¸¦ º¯È­½ÃŰ´Â ¼ººÐ ¶Ç´Â ÀÔÀÚ·Î ÀÌ·ç¾îÁø.
  • fluid attenuated inversion recovery
    ¾×ü °¨¼è ¿ªÀü ȸº¹
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
computer model A mathematical representation of the functioning of a system, presented in the form of a computer program.
Synonym: computer simulation.
(05 Mar 2000)
concerted model A model used to explain the allosteric form of cooperativity; in this model, an oligomeric protein can exist in two conformational states in the absence of the ligand; these states are in equilibrium and the one that is predominant has a lower affinity for the ligand (which binds to the protein in a rapid equilibrium fashion).
Synonym: concerted model.
(05 Mar 2000)
multiplicative model A model in which the joint effect of two or more causes is the product of their effects if they were acting alone.
(05 Mar 2000)
multistage model A mathematical model, mainly for carcinogenesis, based on the theory that a specific carcinogen may affect one among a number of stages in the development of cancer.
(05 Mar 2000)
continuous time model <epidemiology> A model in which the system changes continuously over time. Derivatives (e.g. DY/dt ) are the mathematical formalism for describing such continuous change. The differential equation which embodies a model provides the values of these derivatives at any particular time point; calculus or a computer can then be used to move the state of the model forwards in time.
Continuous models have the advantage over discrete time models in that they are more amenable to algebraic manipulation, although they are slightly harder to implement on a computer.
The same as a differential equation model.
(05 Dec 1998)
cooperativity model A model used to explain the property of cooperativity observed in certain enzymes; e.g., allosterism or hysteresis.
(05 Mar 2000)
seir model <epidemiology> A class of compartmental prevalence models, with compartments Susceptible, Latent (Exposed), Infectious and Recovered. Takes its name from a common notation. In the notation used in the course, this would be an XHYZ model. Many permutations possible.
(05 Dec 1998)
sliding filament model <cell biology> Generally accepted model for the way in which contraction occurs in the sarcomere of striated muscle, by the sliding of the thick filaments relative to the thin filaments.
(18 Nov 1997)
spawner-recruit model Biological model that relates the number of recruits or mature spawners in one generation to the number of spawners in the previous generation.
(09 Oct 1997)
statistical model A formal representation for a class of processes that allows a means of analyzing results from experimental studies, such as the Poisson model or the general linear model; it need not propose a process literally interpretable in the context of the individual case.
(05 Mar 2000)
stochastic model <epidemiology> A mathematical model which takes into consideration the presence of some randomness in one or more of its parameters or variables. The predictions of the model therefore do not give a single point estimate but a probability distribution of possible estimates. Contrast with deterministic.
We might distinguish demographic stochasticity which arises from the discreteness of individuals and individual events such as birth, and environmental stochasticity arising from more-or-less unpredictable interactions with the outside world.
(05 Dec 1998)
nursing model A set of abstract and general statements about the concepts that serve to provide a framework for organizing ideas about clients, their environment, health and nursing.
(05 Mar 2000)
surface envelope model <biology> A way of treating the hydrodynamics of a ciliary field by considering the whole surface of the ciliate to have an undulating surface. The undulations arise because of metachronism.
(18 Nov 1997)
deterministic model <epidemiology> A mathematical model in which the parameters and variables are not subject to random fluctuations, so that the system is at any time entirely defined by the initial conditions chosen. Contrast with a stochastic model.
(05 Dec 1998)
discrete time model <epidemiology> A model in which the system jumps from one state to the next at fixed intervals or timesteps. These difference models are simple to understand but often difficult to analyse; Contrast continuous time models.
The parameters in such a model refer to the amount of change over the finite timestep; they are sometimes referred to as finite rates.
In a (rather precise) sense, a differential equation is what you eventually get from a difference equation when you let the timestep get smaller and smaller and smaller.
(05 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fluid power
    À¯Ã¼µ¿·Â
  • fluid pressure
    À¯Ã¼ ¾Ð·Â;À¯¾Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á